Earlier this year, the U.S. Food and Drug Administration (FDA) has received reports of SERIOUS HARM in patients in patients who are physically dependent on opioid pain medications and having these medications discontinued abruptly or the dosage rapidly reduced. Reports state that the effects include uncontrollable pain, suicide, serious withdrawal symptoms, and psychological distress. Read the full FDA warning at https://www.fda.gov/drugs/drug-safety-and-availability/fda-identifies-harm-reported-sudden-discontinuation-opioid-pain-medicines-and-requires-label-changes